Skip to main content
INDV
NASDAQ Life Sciences

Indivior-Supernus Merger Closes; $650M Term Loan Funds $1B Special Dividend

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Neutral
Importance info
9
Price
$35.56
Mkt Cap
$4.175B
52W Low
$27.68
52W High
$42.81
52W Position info
28% above low
Off High info
17% below high
Rel. Volume info
1.9× avg
Market data snapshot near publication time

INDV sits 28% above its 52-week low of $27.68 on elevated volume (1.9× avg).

Summary

Indivior and Supernus completed their merger of equals on November 2, 2026, renaming the combined company Supernus, Inc. (SUPN) and drawing a $650 million term loan to help fund the $1.0 billion special dividend.


Key Events · M&A and Partnerships · INDV

  • Merger of Equals Closes

    At 8:18 a.m. ET on November 2, 2026, Supernus merged into an Indivior subsidiary; each Supernus share converted into 1.5401 Indivior shares, and Indivior was renamed Supernus, Inc.

  • $650M Term Loan Borrowed at Close

    To help fund the $1.0 billion aggregate special dividend, the combined company drew the full $650,000,000 senior secured term loan from Citibank on the Closing Date, with the remainder from cash on hand.

  • Ownership Split 56.5% / 43.5%

    On a fully diluted basis, legacy Indivior stockholders own approximately 56.5% of the combined company and former Supernus stockholders approximately 43.5%.

  • New Leverage Covenants

    The credit agreement requires a maximum Total Net Leverage Ratio of 3.25x through 2027, stepping to 3.00x, and a minimum Consolidated Interest Coverage Ratio of 3.00x.


Analysis · INDV · Life Sciences

The merger of equals is complete, and the combined company starts life with meaningful secured leverage. Indivior has been renamed Supernus, Inc.; Supernus shareholders received 1.5401 Indivior shares per share, leaving legacy Indivior holders with about 56.5% of the combined company versus 43.5% for former Supernus holders. To fund the previously announced $1.0 billion aggregate special dividend, the combined company borrowed the full $650 million term loan from Citibank on day one, with the balance from cash on hand. The credit agreement carries maximum Total Net Leverage Ratio covenants of 3.25x stepping to 3.00x. At closing, the entire legacy Indivior executive team (CEO, CFO, CCO, CLO) exited with roughly $8.1 million in combined salary continuation and lump-sum payments. Supernus's Jack Khattar takes over as CEO, and a new eight-person board is split evenly between the two companies. Shares trade under SUPN from November 3, 2026.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 52.4% of the 208 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -1.91%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, INDV was trading at $35.56 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.2B. The 52-week trading range was $27.68 to $42.81. This filing was assessed with neutral market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

INDV - Latest Insights

INDV
Oct 29, 2026, 4:09 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $35.25
Real-time Price: $28.96 info
Change: -$6.29 (-18%) info
Market Cap: $6.016B info
INDV
Oct 29, 2026, 8:14 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $36.51
Real-time Price: $28.96 info
Change: -$7.55 (-21%) info
Market Cap: $6.016B info
INDV
Oct 29, 2026, 7:00 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $34.44
Real-time Price: $28.96 info
Change: -$5.48 (-16%) info
Market Cap: $6.016B info
INDV
Oct 29, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $34.44
Real-time Price: $28.96 info
Change: -$5.48 (-16%) info
Market Cap: $6.016B info
INDV
Oct 06, 2026, 7:15 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $35.99
Real-time Price: $28.96 info
Change: -$7.03 (-20%) info
Market Cap: $6.016B info